GlassScriptPhysician profile
Rakesh H Patel
NPI 1053355693
$2,271.16
in general payments reported to CMS, 2019-2025
22 companies · $28.99 in 2025
The $28.99 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $291 · 2021: $172 · 2022: $148 · 2023: $436 · 2024: $429 · 2025: $28.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $745.30 | 2019-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $331.85 | 2019-2023 | Xtampza |
| Spr Therapeutics, INC | $139.43 | 2024 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $136.82 | 2019-2020 | |
| Novo Nordisk INC | $122.88 | 2019 | |
| Relievant Medsystems, INC. | $122.60 | 2023 | Intracept |
| Olympus America INC. | $120.29 | 2019 | |
| Livanova USA, INC. | $99.70 | 2023 | Lifesparc |
| Biodelivery Sciences International, INC. | $89.31 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $45.71 | 2024-2025 | |
| Tactile Systems Technology INC | $42.91 | 2023 | Entre Plus, Flexitouch Plus |
| Valinor Pharma, LLC | $41.84 | 2024 | Movantik |
| Pfizer INC. | $34.42 | 2019-2020 | |
| Cvrx, INC. | $33.82 | 2024 | Barostim Neo System |
| Sentynl Therapeutics, INC. | $27.98 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $25.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.41 | 2024 | Jardiance |
| Endo Pharmaceuticals INC. | $24.36 | 2024 | Xiaflex |
| Grt US Holding, INC. | $19.61 | 2021 | |
| Nevro Corp. | $17.22 | 2019 | |
| Shionogi INC | $13.01 | 2019 | |
| Horizon Therapeutics Plc | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.